fbpx
QQQ
+ 3.17
344.57
+ 0.91%
DIA
+ 2.29
336.49
+ 0.68%
SPY
+ 2.38
420.22
+ 0.56%
TLT
+ 0.36
142.91
+ 0.25%
GLD
+ 0.28
165.86
+ 0.17%

Puration, Kaly Confirm M&A Deal, Say Research Underway On CBD, Coronavirus Symptoms

March 3, 2020 3:33 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Puration, Kaly Confirm M&A Deal, Say Research Underway On CBD, Coronavirus Symptoms

Puration Inc (OTC:PURA) and Kali-Extracts (OTC:KALY) said Monday that a planned acquisition by Pura of Kaly's CBD confections operations is underway. 

Kaly is focusing its business on cannabis extract biopharmaceuticals, and its leading research has been on the treatment of respiratory conditions, the companies said. 

Kaly has filed a new patent application on its CBD formulation for the symptoms of COPD and similar respiratory conditions, the companies said. The company has also filed for a trademark on the name RespRx as a brand of CBD for COPD symptoms and other conditions that cause respiratory inflammation. 

The company said it is evaluating its proprietary CBD extract formulation as a treatment for symptoms of coronavirus. 

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Posted-In:

Cannabis M&A Markets

Related Articles

Puration Posts Q1 Results, Touts 173% Revenue Spike

Puration Inc. (OTCPK: PURA), an extraction cannabis company, announced Thursday its financial earnings for the first quarter of 2020. read more

The Week In Cannabis: Davos, Aphria's Funding, Moves In Alaska, New York And Vermont

Pura Expands Co-Packing Deal With Alkame, Pursues $2T 'Combined Horizontal Market Opportunity'

Puration Inc. (PINK: PURA), a manufacturer of CBD infused sports drinks, is poised to expand its co-packing partnership with health and wellness company Alkame Holdings Inc. (PINK: ALKM). read more

PAOG Closes Acquisition Of PURA's Cannabis Cultivation Operation

The months-long process to sell Puration Inc.'s (OTCPK: PURA) cultivation business to PAOG Group, Inc. read more